FineMark National Bank & Trust’s Avanos Medical AVNS Stock Holding History

FineMark National Bank & Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-931	Closed	-$34K	–	415
2016 Q4	$34K	Buy	931 +100	+12%	+$3.57K	﹤0.01%	708
2016 Q3	$29K	Sell	831 -34	-4%	-$1.19K	﹤0.01%	726
2016 Q2	$28K	Hold	865	–	–	﹤0.01%	748
2016 Q1	$25K	Sell	865 -31	-3%	-$826	﹤0.01%	736
2015 Q4	$30K	Hold	896	–	–	﹤0.01%	727
2015 Q3	$25K	Sell	896 -118	-12%	-$4.12K	﹤0.01%	796
2015 Q2	$41K	Hold	1,014	–	–	0.01%	696
2015 Q1	$50K	Sell	1,014 -484	-32%	-$22.4K	0.01%	669
2014 Q4	$68K	Buy	+1,498	New	+$58.9K	0.01%	583

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FineMark National Bank & Trust's AVNS Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 931 shares — an estimated $34K sold.

FineMark National Bank & Trust first reported a position in AVNS in Q4 2014 and held it in 9 quarters. The position peaked at $68K in Q4 2014. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

FineMark National Bank & Trust reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 931 Avanos Medical shares in Q1 2017, an estimated $34K.
FineMark National Bank & Trust first reported a position in Avanos Medical in Q4 2014 and held it in 9 quarters.
FineMark National Bank & Trust's Avanos Medical position peaked at $68K in Q4 2014.
335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.